Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. junior Avg
|
|
New words:
al, allegedly, AMT, Australian, Bank, banking, Blvd, Boca, briumvi, BRIUMVITM, captioned, Carrington, climate, Colorado, complaint, Connecticut, dismissed, England, enlarging, hoc, inflationary, Interbank, IRA, isolated, military, Mill, mistake, monetize, Morrisville, NI, penalize, poor, pregnant, prejudice, PTAB, purportedly, purpose, Raton, reception, refund, reinstated, Russian, Secretary, Shapiro, Southern, SWIFT, TGR, Treasurer, undermining, Utah, Virginia, wider, withdrew, women
Removed:
AbbVie, achieved, ADCC, ADCP, AEs, affinity, alkylating, allocation, alpha, analytically, animal, anticipation, antigen, assign, assuming, atezolizumab, attack, attaining, attribution, avelumab, avoiding, baseline, bendamustine, beta, billed, bind, binding, biochemical, block, blockade, bone, Bromodomain, cancer, capability, Caribe, casein, CDC, cellular, chimeric, closely, closer, cohort, combining, complimentary, component, constellation, CR, curable, cycle, cytogenetic, cytotoxicity, Dana, defining, demographic, diagnosed, diarrhea, diffuse, discontinued, display, disseminated, DLBCL, domain, downstream, draft, drastically, durvalumab, duvelisib, Edition, effector, EGFR, EHA, elude, enhanced, envision, epitope, epsilon, equipment, escalation, evaluable, exploratory, explore, Extra, extranodal, Farber, FBR, feasible, fight, Floor, France, functional, gamma, Gansevoort, generation, generically, GENUINE, Gilead, glycoengineered, Gribben, growing, Haematology, hematopoietic, hepatic, Humphrey, ibrutinib, idelalisib, identification, immunity, immunotherapy, improved, improving, incurable, indiscriminate, indolent, induction, inhibited, inhibiting, inhibitory, interaction, intervention, intracellular, introducing, invent, isoform, Israel, ITK, iwCLL, Janssen, John, Ladenburg, Lancet, Leasehold, lenalidomide, leverage, leveraged, lymphoid, MALT, manageable, manuscript, marrow, median, mentioned, mg, mice, microenvironment, molecule, mouse, move, MRD, multicenter, naive, NaN, neutropenia, NMZL, nodal, noted, nude, ORR, pathobiology, peripheral, pharmacologic, pivotal, potency, potent, Preclinically, programmed, progression, protein, Raji, Raleigh, ranging, ratio, Raymond, realistically, reposition, residual, revealed, rituximab, Robinson, run, scalable, scaling, selective, selectively, Senate, sharing, Silencing, solid, splenic, Stockholm, subtype, suitable, SunTrust, Sweden, Thalmann, threshold, titled, TLS, trafficking, translation, triple, TXK, typical, undergone, undetectable, unexpectedly, uniquely, unnecessarily, update, upregulated, venetoclax, vivo, Wainwright, xenograft
Filing tables
Filing exhibits
Related press release
Associated TGTX transcripts
TGTX similar filings
Filing view
External links